PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,238,287,000 | +202.3% | 70,827 | +203.7% | 0.04% | +135.3% |
| Q3 2020 | $1,402,178,000 | +16.1% | 23,323 | +1.4% | 0.02% | -10.5% |
| Q2 2020 | $1,207,439,000 | +98145.6% | 23,012 | -37.2% | 0.02% | 0.0% |
| Q1 2020 | $1,229,000 | -2.1% | 36,639 | +32.1% | 0.02% | +90.0% |
| Q4 2019 | $1,256,000 | -55.9% | 27,736 | -58.1% | 0.01% | -60.0% |
| Q4 2018 | $2,845,000 | +161.7% | 66,122 | +198.9% | 0.02% | +316.7% |
| Q3 2018 | $1,087,000 | +422.6% | 22,122 | +240.9% | 0.01% | +500.0% |
| Q2 2018 | $208,000 | -0.5% | 6,490 | -3.1% | 0.00% | 0.0% |
| Q1 2018 | $209,000 | -18.0% | 6,701 | +25.2% | 0.00% | -50.0% |
| Q2 2017 | $255,000 | -15.0% | 5,351 | -18.8% | 0.00% | -33.3% |
| Q1 2017 | $300,000 | -77.1% | 6,587 | -82.8% | 0.00% | -75.0% |
| Q3 2016 | $1,312,000 | -80.6% | 38,346 | -49.7% | 0.01% | -87.0% |
| Q1 2015 | $6,779,000 | -6.9% | 76,297 | -7.1% | 0.09% | +7.0% |
| Q4 2014 | $7,279,000 | +3064.8% | 82,097 | +3183.9% | 0.09% | +4200.0% |
| Q2 2014 | $230,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |